Impact of early access to a palliative/supportive care intervention on pain management in patients with cancer

Annals of Oncology : Official Journal of the European Society for Medical Oncology
E BandieriM Luppi

Abstract

No study has so far addressed whether differences do exist in the management of cancer pain between patients receiving usual care by primary specialists and those receiving early palliative/supportive intervention. A multicentre cross-sectional study in 32 Italian Hospitals has included 1450 patients, receiving analgesic therapy for cancer pain: 602 with access to primary specialist alone (standard care, SC) and 848 with early access to a palliative/supportive care (ePSC) team, concomitant with primary oncology care. Statistically significant differences in the analgesic drug administration according to care model have been evident: non-opioids were more frequently used in SC (9.5% versus 2%; P<0.001), while strong opioids in ePSC group (80% versus 63%; P<0.001). The number of patients with severe pain was lower in ePSC compared with SC group (31% versus 17%; P<0.001). Results of multivariate analysis have shown that ePSC integrated with primary oncologic care (relative risk 0.69; 95% confidence interval 0.48-0.99; P=0.045) was an independent factor associated with a 31% reduced risk of suffering from severe pain. An ePSC team provides the most effective standard of analgesic therapy for cancer pain. A randomized clinical trial...Continue Reading

References

Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
May 15, 2003·American Journal of Epidemiology·Louise-Anne McNuttJean Paul Hafner
Apr 25, 2006·Journal of Palliative Medicine·Ernesto VignaroliEduardo Bruera
Mar 16, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M H J van den Beuken-van EverdingenJ Patijn
Jul 18, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S DeandreaG Apolone
Jan 24, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M CostantiniG Miccinesi
Feb 4, 2009·Critical Reviews in Oncology/hematology·Carla Ripamonti, Elena Bandieri
Feb 27, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H BreivikL Dow
Mar 14, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E BandieriC Ripamonti
Apr 2, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D SichettiUNKNOWN ECAD Working Group
Jul 28, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eduardo Bruera, David Hui
Sep 8, 2010·The New England Journal of Medicine·Jennifer S TemelThomas J Lynch

❮ Previous
Next ❯

Citations

Nov 15, 2013·Journal of Palliative Medicine·Michael RabowDavid Weissman
Jul 27, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Matti S Aapro
Jan 7, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Enrico VasileAndrea Antonuzzo
Dec 10, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Wiebke JensenKarin Oechsle
Jul 28, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sebastiano MercadanteAlessandra Casuccio
Mar 25, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ilene H ZuckermanCandice Yong
May 8, 2015·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Takuro KoboriShogo Tokuyama
Apr 9, 2013·Leukemia Research·Elena BandieriMario Luppi
Jun 3, 2015·Bulletin du cancer·Stéphanie Ranque GarnierWadih Rhondali
Oct 5, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Yong Joo LeeChul-Min Kim
Apr 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maria Teresa GrecoGiovanni Apolone
Apr 16, 2015·Journal of Oncology Practice·Stephen H TaplinMichael P Kosty
Sep 29, 2017·Journal of Palliative Medicine·Richard A TaylorJ Nicholas Dionne-Odom
Aug 3, 2019·Journal of Palliative Medicine·Emily J Martin, Joshua A Jones
Dec 7, 2014·The Oncologist·David HuiEduardo Bruera
Jul 8, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·S ManfridaV Valentini
May 15, 2013·MMW Fortschritte der Medizin·Christoph Aulmann, Irmtraud Hainsch-Müller
May 20, 2017·Clinical Journal of Oncology Nursing·Linda H EatonChao Yeh
Oct 2, 2020·International Journal of Environmental Research and Public Health·Elena BandieriMario Luppi
Jun 3, 2014·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Takuro KoboriShogo Tokuyama
Jul 21, 2017·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·A Sandgren, P Strang
Nov 15, 2018·Cancers·Mario LuppiAdriano Venditti
Jun 16, 2019·BMJ Supportive & Palliative Care·Elena BandieriMario Luppi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.